Log in
NASDAQ:BCRX

BioCryst Pharmaceuticals Insider Trades

$3.82
+0.09 (+2.41 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.70
Now: $3.82
$3.84
50-Day Range
$3.37
MA: $3.74
$4.03
52-Week Range
$1.38
Now: $3.82
$6.29
Volume4.33 million shs
Average Volume4.37 million shs
Market Capitalization$674.50 million
P/E RatioN/A
Dividend YieldN/A
Beta2.67

Insider Trades

BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Buying and Selling Activity

Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $394,320.00
Insider Selling (Last 12 Months): $0.00

Insider Buying and Selling by Quarter


BioCryst Pharmaceuticals (NASDAQ BCRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2020Anthony DoyleCFOBuy54,000$4.08$220,320.0054,000  
11/18/2019Alane P BarnesVPBuy20,000$1.45$29,000.00102,061  
11/18/2019Jon P StonehouseCEOBuy50,000$1.45$72,500.00778,086  
11/18/2019Kenneth B Lee JrDirectorBuy5,000$1.45$7,250.0015,252  
11/18/2019Megan SniecinskiInsiderBuy45,000$1.45$65,250.0045,000  
5/22/2019Steve AselageDirectorBuy3,000$3.57$10,710.005,000  
5/17/2019Thomas R Staab IIInsiderSell9,750$7.65$74,587.50134,926  
5/15/2019Thomas R Staab IIInsiderSell11,750$7.81$91,767.50137,176  
5/13/2019Thomas R Staab IIInsiderSell19,500$7.70$150,150.00142,426  
5/9/2019Thomas R Staab IICFOSell9,750$7.63$74,392.50142,426  
5/6/2019Thomas R Staab IICFOSell9,000$7.75$69,750.00140,426  
5/2/2019Thomas R Staab IICFOSell7,750$7.30$56,575.00140,426  
4/4/2019Thomas R Staab IIInsiderSell7,500$8.81$66,075.00140,176  
3/12/2019Steve AselageDirectorBuy2,000$8.30$16,600.002,000  
1/28/2019Lynne PowellVPSell12,000$9.75$117,000.006,000  
1/28/2019Thomas R Staab IICFOSell5,000$9.85$49,250.00133,426  
1/25/2019Lynne PowellVPSell6,000$9.60$57,600.006,000  
1/18/2019Lynne PowellVPSell2,000$9.40$18,800.002,000  
1/16/2019Lynne PowellVPSell3,046$9.27$28,236.423,046  
1/14/2019Lynne PowellVPSell954$9.20$8,776.80954  
12/18/2018William P SheridanCMOSell20,488$7.58$155,299.042,725  
12/10/2018Lynne PowellVPSell4,000$9.06$36,240.002,000  
12/4/2018Thomas R Staab IIInsiderSell3,922$9.45$37,062.90  
11/30/2018Alane P BarnesVPSell44,290$9.07$401,710.30  
11/23/2018Thomas R Staab IIInsiderSell15,500$9.32$144,460.00142,383  
11/20/2018Lynne PowellVPSell15,470$8.55$132,268.508,798  
11/20/2018Thomas R Staab IIInsiderSell11,198$8.67$97,086.66137,458  
11/8/2018Lynne PowellVPSell5,280$8.15$43,032.008,905  
11/8/2018Thomas R Staab IIInsiderSell14,087$8.12$114,386.44138,055  
11/5/2018Lynne PowellVPSell100$8.00$800.008,705  
11/5/2018Thomas R Staab IIInsiderSell215$8.00$1,720.00137,598  
11/2/2018Thomas R Staab IICFOSell10,856$7.84$85,111.04144,739  
11/1/2018Lynne PowellVPSell1,544$7.51$11,595.448,605  
10/19/2018Lynne PowellVPSell100$7.50$750.0010,149  
10/19/2018Thomas R Staab IIInsiderSell3,150$7.45$23,467.50140,533  
10/3/2018Thomas R Staab IIInsiderSell9,850$7.24$71,314.00140,633  
8/9/2018William P SheridanCMOSell62,500$7.03$439,375.0085,713  
6/1/2018William P SheridanCMOSell42,112$6.30$265,305.6063,170  
11/13/2017William P SheridanCMOSell64,310$4.72$303,543.20  
9/18/2017Fred E CohenDirectorSell54,250$5.42$294,035.00173,660  
3/20/2017Thomas R Staab IICFOSell3,250$9.20$29,900.00144,710  
3/10/2017Thomas R Staab IIInsiderSell3,250$9.06$29,445.00120,563  
3/8/2017Thomas R Staab IIInsiderSell6,500$8.43$54,795.00123,813  
3/6/2017Thomas R Staab IIInsiderSell3,250$7.90$25,675.00120,563  
12/19/2016Thomas R Staab IIInsiderSell3,250$7.45$24,212.50127,437  
9/14/2016Alane P BarnesVPSell8,357$4.27$35,684.3979,377  
8/25/2016Yarlagadda S BabuVPSell30,000$4.06$121,800.00111,428  
8/16/2016Bros. Advisors Lp BakerMajor ShareholderSell4,046,590$5.00$20,232,950.00  
8/12/2016Thomas R Staab IIInsiderSell5,864$5.18$30,375.52128,745  
8/9/2016Thomas R Staab IIInsiderSell14,577$4.43$64,576.11130,051  
1/28/2016Bros. Advisors Lp Bakermajor shareholderBuy88,345$6.95$613,997.7523,459  
1/22/2016Bros. Advisors Lp Bakermajor shareholderBuy106,800$7.28$777,504.0023,459  
1/20/2016Bros. Advisors Lp Bakermajor shareholderBuy52,695$6.87$362,014.6523,459  
1/19/2016Bros. Advisors Lp Bakermajor shareholderBuy92,200$7.12$656,464.0023,459  
1/15/2016Bros. Advisors Lp Bakermajor shareholderBuy200,000$7.46$1,492,000.0023,459  
12/21/2015Thomas R Staab IICFOSell3,052$10.86$33,144.72136,592  
12/17/2015Thomas R Staab IICFOSell3,000$10.49$31,470.00139,644  
7/20/2015Thomas R Staab IICFOSell3,500$16.50$57,750.00  
6/22/2015Thomas R Staab IICFOSell3,750$16.00$60,000.00  
6/19/2015Alane P BarnesVPSell3,000$15.00$45,000.00  
6/19/2015Jon P StonehouseCEOSell20,000$15.02$300,400.00  
6/19/2015Thomas R Staab IICFOSell16,375$14.36$235,145.00  
6/19/2015William P SheridanCMOSell70,389$15.05$1,059,354.45  
6/5/2015Thomas R Staab IICFOSell6,000$12.75$76,500.00  
5/18/2015Thomas R Staab IICFOSell3,000$11.00$33,000.00  
3/19/2015Yarlagadda S BabuVPSell12,105$10.16$122,986.80  
3/5/2015Yarlagadda S BabuVPSell37,400$10.59$396,066.00  
3/4/2015Yarlagadda S BabuVPSell10,495$10.50$110,197.50  
2/20/2015Nancy J HutsonDirectorBuy10,000$10.27$102,700.00  
12/30/2014William P SheridanCMOSell128,399$12.36$1,587,011.64  
12/29/2014Thomas R Staab IICFOSell9,500$12.56$119,320.00  
12/29/2014William P SheridanCMOSell105,295$12.43$1,308,816.85  
8/27/2014Thomas R Staab IICFOSell10,000$13.58$135,800.00  
7/1/2014Thomas R Staab IICFOSell3,125$13.00$40,625.00  
6/23/2014Thomas R Staab IICFOSell3,125$12.49$39,031.25  
6/17/2014Thomas R Staab IICFOSell3,125$12.00$37,500.00  
3/14/2014Thomas Staab IICFOSell3,125$11.24$35,125.00126,616  
3/6/2014Kenneth Lee, Jr.DirectorSell12,665$12.69$160,718.8510,252  
11/12/2013George AbercrombieDirectorBuy3,000$6.19$18,570.006,000  
8/1/2013Felix BakerMajor ShareholderBuy1,136,364$4.40$5,000,001.60  
3/5/2013George B AbercrombieDirectorBuy3,000$1.23$3,690.00  
12/14/2012Peder JensenDirectorBuy20,000$1.51$30,200.00  
(Data available from 1/1/2013 forward)
This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.